BR112018076553A2 - composição de dois componentes. - Google Patents

composição de dois componentes.

Info

Publication number
BR112018076553A2
BR112018076553A2 BR112018076553-8A BR112018076553A BR112018076553A2 BR 112018076553 A2 BR112018076553 A2 BR 112018076553A2 BR 112018076553 A BR112018076553 A BR 112018076553A BR 112018076553 A2 BR112018076553 A2 BR 112018076553A2
Authority
BR
Brazil
Prior art keywords
component composition
aas
immediate
novel
providing
Prior art date
Application number
BR112018076553-8A
Other languages
English (en)
Inventor
Bjørn Fredrikson John
Original Assignee
Asamedic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asamedic As filed Critical Asamedic As
Publication of BR112018076553A2 publication Critical patent/BR112018076553A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/072—Sealing capsules, e.g. rendering them tamper-proof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

a presente invenção refere-se a uma nova composição de dois componentes compreendendo ácido acetilsalicílico (aas) e que é particularmente útil no fornecimento de uma solução aquosa de aas para administração peroral imediata.
BR112018076553-8A 2016-06-28 2017-06-28 composição de dois componentes. BR112018076553A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20161073 2016-06-28
NO20161073 2016-06-28
PCT/EP2017/065970 WO2018002124A1 (en) 2016-06-28 2017-06-28 Two-component composition

Publications (1)

Publication Number Publication Date
BR112018076553A2 true BR112018076553A2 (pt) 2019-04-02

Family

ID=59285173

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018076553-8A BR112018076553A2 (pt) 2016-06-28 2017-06-28 composição de dois componentes.

Country Status (24)

Country Link
US (2) US11918554B2 (pt)
EP (2) EP3871677A1 (pt)
JP (2) JP2019520377A (pt)
KR (1) KR102397334B1 (pt)
CN (2) CN117982446A (pt)
AU (1) AU2017288465B2 (pt)
BR (1) BR112018076553A2 (pt)
CA (1) CA3027462A1 (pt)
CY (1) CY1124724T1 (pt)
DK (1) DK3474858T3 (pt)
EA (1) EA201990093A1 (pt)
ES (1) ES2897981T3 (pt)
HR (1) HRP20211761T1 (pt)
HU (1) HUE056659T2 (pt)
IL (1) IL263982B (pt)
LT (1) LT3474858T (pt)
MX (1) MX2018015965A (pt)
MY (1) MY195384A (pt)
NZ (1) NZ749230A (pt)
PL (1) PL3474858T3 (pt)
PT (1) PT3474858T (pt)
RS (1) RS62574B1 (pt)
SI (1) SI3474858T1 (pt)
WO (1) WO2018002124A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018002124A1 (en) 2016-06-28 2018-01-04 Asamedic As Two-component composition
EP3501523A1 (en) * 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
WO2020150460A1 (en) * 2019-01-18 2020-07-23 Milne Iii Donald A Micronized aspirin formulation

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB912894A (en) * 1959-11-02 1962-12-12 Guy Leopold Van Moorleghem Method for the preparing a solution of aspirin for injection and product obtained thereby
FR2320759A1 (fr) 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
AU632602B2 (en) * 1989-08-02 1993-01-07 John David Arnold Method and preparation for reducing risk of myocardial infarction
US5157030A (en) * 1989-08-25 1992-10-20 Alexander Galat Rapidly soluble aspirin compositions and method
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
JPH07157432A (ja) * 1993-12-07 1995-06-20 Daikyo Yakuhin Kogyo Kk 貼付剤
GB9701160D0 (en) 1997-01-21 1997-03-12 Parkinson Sidney Medicament dispenser
IT1292677B1 (it) 1997-02-28 1999-02-11 Bormioli Metalplast Spa Confezione per mantenere separati dei prodotti prima dell'uso.
US5776431A (en) 1997-03-26 1998-07-07 Galat; Alexander Water-soluble aspirin composition
JP4126405B2 (ja) * 1998-02-02 2008-07-30 甲陽ケミカル株式会社 芳香族カルボン酸類の溶解度向上化水溶液
NO309761B1 (no) 1999-05-03 2001-03-26 Anders Aelveborn Beholder eller kapsel for adskilt oppbevaring av to- komponents blandbare materialer
GB0018322D0 (en) 2000-07-27 2000-09-13 Boots Co Plc Pharmaceutical compositions
US7029701B2 (en) 2000-09-11 2006-04-18 Andrx Pharmaceuticals, Llc Composition for the treatment and prevention of ischemic events
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AU2002311554A1 (en) 2002-06-25 2004-01-06 Nokia Corporation Routing method and network element
ITMI20022619A1 (it) 2002-12-11 2004-06-12 Ind Italiana Integratori Trei S P A Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.
CN1418635A (zh) * 2002-12-19 2003-05-21 王登之 治疗感冒发热的阿司匹林口腔崩解片及其制备方法
EP1621200A1 (en) * 2004-07-26 2006-02-01 Fournier Laboratories Ireland Limited Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
US7598233B2 (en) * 2005-03-28 2009-10-06 Kowa Co., Ltd. Method for treating thrombosis
US20070092561A1 (en) * 2005-06-24 2007-04-26 Don Milne Water-Soluble Aspirin Composition
US7614496B2 (en) 2005-08-29 2009-11-10 Steven Dvorak Aqueous solution of an analgesic and a dispenser therefor
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
CN101632647A (zh) 2008-07-21 2010-01-27 北京迈劲医药科技有限公司 阿司匹林与碱性药物组成的复方制剂的制备方法
US20100125242A1 (en) 2008-11-15 2010-05-20 Pharmstar Pharmaceuticals, Inc. Emergency dose medication administration device
MX362949B (es) * 2008-12-04 2019-02-27 Yu Chongxi Composiciones de alta penetracion y sus aplicaciones.
US8173625B2 (en) 2009-05-08 2012-05-08 Theaprin Pharmaceuticals Inc. Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
US8580853B2 (en) 2011-06-13 2013-11-12 Howard PHYKITT Analgesic composition and method of making the same
MX357035B (es) * 2012-09-25 2018-06-25 Bayer Pharma AG Combinacion de regorafenib y acido acetilsalicilico para el tratamiento del cancer.
ES2644373T3 (es) 2013-10-23 2017-11-28 Bayer Healthcare Llc Comprimido efervescente que contiene elevado nivel de aspirina
EP2777802B1 (en) 2013-12-03 2016-03-16 Capsugel Belgium NV Multi-compartment dosage form articles
WO2017001468A1 (en) 2015-07-02 2017-01-05 Asamedic As Two-component composition
WO2018002124A1 (en) 2016-06-28 2018-01-04 Asamedic As Two-component composition
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt

Also Published As

Publication number Publication date
HUE056659T2 (hu) 2022-03-28
US11369581B2 (en) 2022-06-28
CN117982446A (zh) 2024-05-07
IL263982B (en) 2022-03-01
US20220218724A1 (en) 2022-07-14
LT3474858T (lt) 2021-12-27
MX2018015965A (es) 2019-05-22
US20210212976A1 (en) 2021-07-15
EP3474858A1 (en) 2019-05-01
MY195384A (en) 2023-01-18
WO2018002124A1 (en) 2018-01-04
AU2017288465A1 (en) 2019-01-17
KR102397334B1 (ko) 2022-05-11
SI3474858T1 (sl) 2022-01-31
KR20190040184A (ko) 2019-04-17
NZ749230A (en) 2023-05-26
CN109789152A (zh) 2019-05-21
DK3474858T3 (da) 2021-11-22
EP3871677A1 (en) 2021-09-01
EA201990093A1 (ru) 2019-07-31
CY1124724T1 (el) 2022-07-22
IL263982A (en) 2019-01-31
RS62574B1 (sr) 2021-12-31
US11918554B2 (en) 2024-03-05
PL3474858T3 (pl) 2022-01-17
CA3027462A1 (en) 2018-01-04
PT3474858T (pt) 2021-11-22
EP3474858B1 (en) 2021-08-18
HRP20211761T1 (hr) 2022-02-18
AU2017288465B2 (en) 2019-10-10
ES2897981T3 (es) 2022-03-03
JP2019520377A (ja) 2019-07-18
JP2023027071A (ja) 2023-03-01

Similar Documents

Publication Publication Date Title
CL2017003389A1 (es) Composiciones de pienso para animales y usos de las mismas.
CO2017005626A2 (es) Una composición que comprende bacteroides thetaiotaomicron
BR112018003784A2 (pt) nanopartículas de polinucleotídeo para a modulação da expressão gênica e sua utilização
CL2016000839A1 (es) Composiciones para modular la expresión de c9orf72.
UY35980A (es) Derivados de sulfamoilpirrolamida como inhibidores del hbv y composiciones farmacéuticas que los contienen
SV2018005643A (es) Composiciones de insulina de rapida accion
BR112018076553A2 (pt) composição de dois componentes.
BR112017027567A2 (pt) proteínas de fusão para inibir a angiogênese
PE20171238A1 (es) Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos
BR112016024494A2 (pt) análogos de peptídeo com sonda(s) de aminoácidos ramificados
BR112018003178A2 (pt) absorvente feminino com braçadeiras de barreira
BR112018076765A2 (pt) métodos para inibir a conversão de colina em trimetilamina (tma)
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
BR112016028697A2 (pt) artigos que fornecem fragrâncias de longa duração
ECSP17074919A (es) Piroglutamato de vortioxetina
UY36967A (es) Tratamiento de la oligo-ovulación relacionada con esteatosis hepática
BR112017013770A2 (pt) composições de inibidor de nitrificação microencapsuladas
ECSP18018793A (es) Compuestos útiles para inhibir ror-gamma-t
BR112015027824A2 (pt) composições de vitamina e em pó
BR112018008588A2 (pt) composição, e, processo para preparar uma composição.
BR112017020450A2 (pt) ?suporte de dentes?
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
BR112017005174A2 (pt) inibidor de corrosão biológica para metais
BR112018003714A8 (pt) Composições de ácido de peso aumentado que compreendem aminoácidos

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]